147 related articles for article (PubMed ID: 21777958)
1. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard.
Yoshida A; Seki M; Nasrin S; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Ehlert FJ; Yamada S
Urology; 2011 Sep; 78(3):721.e7-721.e12. PubMed ID: 21777958
[TBL] [Abstract][Full Text] [Related]
2. Fesoterodine, its active metabolite, and tolterodine bind selectively to muscarinic receptors in human bladder mucosa and detrusor muscle.
Yoshida A; Fuchihata Y; Kuraoka S; Osano A; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Yamada S
Urology; 2013 Apr; 81(4):920.e1-5. PubMed ID: 23497983
[TBL] [Abstract][Full Text] [Related]
3. Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
Mansfield KJ; Chandran JJ; Vaux KJ; Millard RJ; Christopoulos A; Mitchelson FJ; Burcher E
J Pharmacol Exp Ther; 2009 Mar; 328(3):893-9. PubMed ID: 19029429
[TBL] [Abstract][Full Text] [Related]
4. Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder.
Maruyama S; Oki T; Otsuka A; Shinbo H; Ozono S; Kageyama S; Mikami Y; Araki I; Takeda M; Masuyama K; Yamada S
J Urol; 2006 Jan; 175(1):365-9. PubMed ID: 16406943
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
Endou M; Hattori Y; Gando S; Kanno M
J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland.
Waldeck K; Larsson B; Andersson KE
J Urol; 1997 Mar; 157(3):1093-7. PubMed ID: 9072550
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic Receptor Binding of Imidafenacin in the Human Bladder Mucosa and Detrusor and Parotid Gland.
Seki M; Ogoda M; Kuraoka S; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Yamada S
Low Urin Tract Symptoms; 2011 Sep; 3(2):64-8. PubMed ID: 26676388
[TBL] [Abstract][Full Text] [Related]
8. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.
Mansfield KJ; Liu L; Mitchelson FJ; Moore KH; Millard RJ; Burcher E
Br J Pharmacol; 2005 Apr; 144(8):1089-99. PubMed ID: 15723094
[TBL] [Abstract][Full Text] [Related]
10. Characterization of muscarinic and P2X receptors in the urothelium and detrusor muscle of the rat bladder.
Ogoda M; Ito Y; Fuchihata Y; Onoue S; Yamada S
J Pharmacol Sci; 2016 May; 131(1):58-63. PubMed ID: 27174863
[TBL] [Abstract][Full Text] [Related]
11. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
[TBL] [Abstract][Full Text] [Related]
12. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
13. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
Dauphin F; Hamel E
J Pharmacol Exp Ther; 1992 Feb; 260(2):660-7. PubMed ID: 1738116
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of muscarinic receptors implicated in rabbit detrusor muscle contraction and activation of inositol phospholipid hydrolysis in rabbit detrusor and parotid gland.
Barras M; Coste A; Eon MT; Guillot E
Fundam Clin Pharmacol; 1999; 13(5):562-70. PubMed ID: 10520729
[TBL] [Abstract][Full Text] [Related]
15. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic Receptor Binding in Rat Bladder Urothelium and Detrusor Muscle by Intravesical Solifenacin.
Ito Y; Kashiwabara M; Yoshida A; Hikiyama E; Onoue S; Yamada S
Biol Pharm Bull; 2016; 39(7):1167-71. PubMed ID: 27374291
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle.
Choppin A; Eglen RM; Hegde SS
Br J Pharmacol; 1998 Jul; 124(5):883-8. PubMed ID: 9692772
[TBL] [Abstract][Full Text] [Related]
18. Influence of tissue integrity on pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex.
Md Anisuzzaman AS; Nishimune A; Yoshiki H; Uwada J; Muramatsu I
J Pharmacol Exp Ther; 2011 Oct; 339(1):186-93. PubMed ID: 21719469
[TBL] [Abstract][Full Text] [Related]
19. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
Nilvebrant L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
[TBL] [Abstract][Full Text] [Related]
20. Characterization of muscarinic receptor binding by the novel radioligand, [(3)H]imidafenacin, in the bladder and other tissues of rats.
Kuraoka S; Ito Y; Wakuda H; Shinozuka K; Onoue S; Yamada S
J Pharmacol Sci; 2016 Jul; 131(3):184-9. PubMed ID: 27430986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
